Browse studies
Find your next paid study
4 recruiting studies matching your filters
Phase 2
A Two-Year Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene
The purpose of this Phase 2b study is to evaluate the safety and tolerability of ultevursen administered via intravitreal injection (IVT) in subjects with Reti…
Retinitis Pigmentosa (RP)Usher Syndrome Type 2Deaf Blind+4 more
Estimated
~$10 – $7,500
Laboratoires TheaNCT06627179
Foundation Fighting Blindness My Retina Tracker Registry
The My Retina Tracker® Registry is sponsored by the Foundation Fighting Blindness and is for people affected by one of the rare inherited retinal degenerative …
Eye Diseases HereditaryRetinal DiseaseAchromatopsia+25 more
Estimated
~$10 – $750
Foundation Fighting BlindnessNCT02435940
Adaptive Optics Imaging of Outer Retinal Diseases
The objective of the study is to collect adaptive optics (AO) retinal images from human subjects with outer retinal diseases (diseases of the outer retina incl…
Retinal DegenerationAge-Related Macular DegenerationRetinitis Pigmentosa+7 more
Estimated
~$10 – $1,125
Food and Drug Administration (FDA)NCT05355415
Phase 1
A Phase 1/2a Study of Subretinal Administration of OpCT-001 Photoreceptor Precursor Cells Derived From iPSCs in Patients With Primary Photoreceptor Disease
Study OpCT-001-101 is a Phase 1/2a first-in-human, multisite, 2-part interventional study to evaluate the safety, tolerability, and the effect on clinical outc…
Primary Photoreceptor DiseaseRetinitis Pigmentosa (RP)Usher Syndrome+6 more
Estimated
~$10 – $8,750
BlueRock TherapeuticsNCT06789445